GT201200295A - Combinacion de un aine y un aminoácido - Google Patents
Combinacion de un aine y un aminoácidoInfo
- Publication number
- GT201200295A GT201200295A GT201200295A GT201200295A GT201200295A GT 201200295 A GT201200295 A GT 201200295A GT 201200295 A GT201200295 A GT 201200295A GT 201200295 A GT201200295 A GT 201200295A GT 201200295 A GT201200295 A GT 201200295A
- Authority
- GT
- Guatemala
- Prior art keywords
- combination
- nsaid
- amino acid
- composition
- ibuprofen
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 title 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010065390 Inflammatory pain Diseases 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- HEFNNWSXXWATRW-JTQLQIEISA-N dexibuprofen Chemical compound CC(C)CC1=CC=C([C@H](C)C(O)=O)C=C1 HEFNNWSXXWATRW-JTQLQIEISA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960001680 ibuprofen Drugs 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN FARMACÉUTICA ORAL QUE COMPRENDE LA COMBINACIÓN DE UNA SAL DE IBUPROFENO O S (+) - IBUPROFENO CON L-ARGININA Y/O SUS SALES FARMACÉUTICAMENTE ACEPTABLES, ADICIONALMENTE, VEHÍCULOS Y/O EXCIPIENTES FARMACÉUTICAMENTE ACEPTABLES; EL PROCESO DE FABRICACIÓN DE LA COMPOSICIÓN Y EL USO DE DICHA COMPOSICIÓN CON ACTIVIDAD TERAPÉUCTICA SINÉRGICA, INDICADA PARA EL TRATAMIENTO DE DOLOR INFLAMATORIO DE MODERADO A SEVERO, FIEBRE E INFLAMACIÓN.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2010004974A MX2010004974A (es) | 2010-05-04 | 2010-05-04 | Combinacion de un aine y un aminoacido. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT201200295A true GT201200295A (es) | 2014-01-03 |
Family
ID=44903664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT201200295A GT201200295A (es) | 2010-05-04 | 2012-10-31 | Combinacion de un aine y un aminoácido |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9186342B2 (es) |
| AR (1) | AR081007A1 (es) |
| BR (1) | BR112012028300A2 (es) |
| CA (1) | CA2798420C (es) |
| CL (1) | CL2012003065A1 (es) |
| CO (1) | CO6592037A2 (es) |
| CR (1) | CR20120554A (es) |
| DO (1) | DOP2012000280A (es) |
| EC (1) | ECSP13012765A (es) |
| ES (1) | ES2424417B1 (es) |
| GT (1) | GT201200295A (es) |
| MX (1) | MX2010004974A (es) |
| PE (2) | PE20130316A1 (es) |
| WO (1) | WO2011138653A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019010692A (es) * | 2019-09-06 | 2022-07-06 | Alparis Sa De Cv | Compuestos de curcumina y aminoácidos básicos. |
| US11969400B2 (en) * | 2021-03-23 | 2024-04-30 | Kumara V. Nibhanipudi | Ibuprofen for symptomatic treatment of diarrheas in HIV patients |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1209667B (it) | 1985-11-12 | 1989-08-30 | Zambon Spa | Composizione effeverscente adattivita' analgesica. |
| IT1197038B (it) * | 1986-08-01 | 1988-11-25 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
| IT1264856B1 (it) * | 1993-06-21 | 1996-10-17 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
| US6727286B2 (en) | 2001-11-02 | 2004-04-27 | Cumberland Pharmaceuticals Inc. | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| CA2462452C (en) | 2001-11-02 | 2006-07-04 | Leo Pavliv | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| CN101889997B (zh) | 2010-07-26 | 2012-10-03 | 石家庄中硕药业集团有限公司 | 一种注射用的含有布洛芬的药物组合物 |
-
2010
- 2010-05-04 MX MX2010004974A patent/MX2010004974A/es active IP Right Grant
-
2011
- 2011-04-28 CA CA2798420A patent/CA2798420C/en not_active Expired - Fee Related
- 2011-04-28 WO PCT/IB2011/000916 patent/WO2011138653A1/es active Application Filing
- 2011-04-28 PE PE2012002113A patent/PE20130316A1/es active IP Right Grant
- 2011-04-28 ES ES201290078A patent/ES2424417B1/es not_active Expired - Fee Related
- 2011-04-28 BR BR112012028300A patent/BR112012028300A2/pt not_active Application Discontinuation
- 2011-04-28 US US13/696,022 patent/US9186342B2/en active Active
- 2011-05-04 AR ARP110101530A patent/AR081007A1/es unknown
-
2012
- 2012-10-30 CR CR20120554A patent/CR20120554A/es unknown
- 2012-10-31 GT GT201200295A patent/GT201200295A/es unknown
- 2012-10-31 DO DO2012000280A patent/DOP2012000280A/es unknown
- 2012-10-31 CL CL2012003065A patent/CL2012003065A1/es unknown
- 2012-11-23 CO CO12212627A patent/CO6592037A2/es not_active Application Discontinuation
-
2013
- 2013-07-15 EC ECSP13012765 patent/ECSP13012765A/es unknown
-
2016
- 2016-02-02 PE PE2016000218A patent/PE20170136A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011138653A1 (es) | 2011-11-10 |
| RU2012151921A (ru) | 2014-06-10 |
| ES2424417B1 (es) | 2014-11-26 |
| PE20130316A1 (es) | 2013-03-17 |
| CO6592037A2 (es) | 2013-01-02 |
| AR081007A1 (es) | 2012-05-30 |
| MX2010004974A (es) | 2011-11-23 |
| ES2424417A2 (es) | 2013-10-01 |
| US9186342B2 (en) | 2015-11-17 |
| CA2798420C (en) | 2018-06-05 |
| CR20120554A (es) | 2013-02-01 |
| DOP2012000280A (es) | 2012-12-31 |
| US20130109754A1 (en) | 2013-05-02 |
| CL2012003065A1 (es) | 2013-01-11 |
| CA2798420A1 (en) | 2011-11-10 |
| ECSP13012765A (es) | 2013-09-30 |
| BR112012028300A2 (pt) | 2016-11-01 |
| ES2424417R1 (es) | 2013-12-20 |
| PE20170136A1 (es) | 2017-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR091876A1 (es) | Combinaciones farmaceuticas para el tratamiento de enfermedades proliferativas | |
| UY32455A (es) | Derivados de aminotetralina, composiciones farmacéuticas que la contienen, y sus usos en terapia | |
| CR11418A (es) | Trans-clomifeno para el sindrome metabolico | |
| AR080491A1 (es) | Formulaciones orales y sales lipofilicas de metilnaltrexona | |
| UY31788A (es) | Formulación farmacéutica sólida con liberación retardada | |
| MX2012005689A (es) | Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos. | |
| CL2013001250A1 (es) | Composicion intravenosa que contiene ibuprofeno y paracetamol combinados en dosis definidas; y uso en el tratamiento del dolor y/o inflamacion. | |
| UY35091A (es) | Formulaciones de liberacion modificada para oprozomib | |
| BR112014014795A2 (pt) | sistema de pélete de multiunidade de liberação imediata | |
| CL2009001841A1 (es) | Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto. | |
| CL2012003119A1 (es) | Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre. | |
| UY31826A (es) | Compuesto peptídico y su uso | |
| ECSP099734A (es) | Composición farmaceutica que comprende la combinación de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante | |
| ECSP15050273A (es) | Formulación oral para el tratamiento de enfermedades cardiovasculares | |
| GT201200295A (es) | Combinacion de un aine y un aminoácido | |
| CY1123933T1 (el) | Σκευασματα παρατεταμενης αποδεσμευσης λοραζεπαμης | |
| CL2007000485A1 (es) | Sal de alisquereno; procedimiento de preparacion; composicion farmaceutica que comprende a dicha sal; y uso del compuesto para el tratamiento de enfermedades que puedan ser moduladas mediante la inhibicion de la renina. | |
| BR112015004115A2 (pt) | composições farmacêuticas compreendendo flurbiprofeno | |
| ES2561813T3 (es) | Aplicación tópica de nimesulida y tiocolchicósido | |
| UY35445A (es) | Ésteres de testosterona de cadena larga lipoequilibrados para la administración oral | |
| AR093717A1 (es) | Composiciones y metodos para el tratamiento de la caries dental | |
| BR112013004714A2 (pt) | "combinações de inibidores de hdac com fármacos de trombocitopenia e seus usos" | |
| CO7170180A2 (es) | Composición farmacéutica inyectable de dexketoprofeno y tramadol | |
| AR067351A1 (es) | Combinacion de picotamida con nafronil | |
| AR084435A1 (es) | Combinacion y composicion para el tratamiento de obesidad |